Elekta to Acquire Impac Medical Systems

(Mountain View, CA, USA), a provider of information systems for managing radiation and medical oncology and related clinical practices. The acquisition will enable Elekta, a supplier of advanced clinical systems for high precision radiation treatment of cancer and for non- or minimally invasive treatment of brain disorders, to offer customers a new, broad range of healthcare information products for clinical, administrative, outcome and decision-support purposes

Elekta will pay U.S.$24 in cash for each share of Impac common stock outstanding, which represents a premium of 22% over the Impac closing price on January 14, 2005, and is equal to a diluted equity value of about $250 million, and an enterprise value of about $190 million.

By joining forces, Elekta and Impac will be able to provide a unique, fully-integrated system that addresses the total spectrum of the cancer care process from diagnosis through treatment planning, treatment delivery, and follow-up, including decision support and cancer registry. Also, the companies' complementary geography presence will allow for more rapid deployment of Impac's systems into Europe and Asia/Pacific, while providing Impac's U.S. customers with greater choice and improved radiation therapy systems. Elekta's customers will be able to improve treatment efficiency through access to the full array of Impac's cancer management systems.

"The acquisition of Impac is an important step in the strategic development of Elekta and our ongoing efforts to improve cancer care, " remarked Dr. Laurent Leksell, president and CEO of Elekta. "The addition of Impac's strong management and software engineering team creates a significant new dimension to our solutions for cancer treatment.






Related Links:
Elekta
Impac Medical Systems